Business
Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast
BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the
About this update from Sangamo Therapeutics, Inc.
[{"type":"text","content":" BRISBANE, Calif.--(BUSINESS WIRE)--\nSangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its second quarter 2022 financial results after the market closes on Thursday, August 4, 2022.\n\nThe press release will be followed by a conference call at 4:30 p.m. ET, which will be open to the public. During the conference call, the company will review its financial results and provide business updates.\n\nParticipants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.\n\nA replay will be available following the conference call, accessible under Events and Presentations.\n\nAbout Sangamo Therapeutics\n\nSangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220728005792/en/\n\nInvestor & Media Inquiries\nLouise Wilkie\[email protected]\[email protected]\n\nSource: Sangamo Therapeutics, Inc.","length":3794,"tagName":"div"}]